Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib

por Ai, Chun-Zhi, Liu, Yong, Li, Wei, Chen, De-Meng, Zhu, Xin-Xing, Yan, Ya-Wei, Chen, Du-Chu, Jiang, Yi-Zhou
Publicado 2017

CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma

por Chen, Du-Chu, Liang, You-De, Peng, Liang, Wang, Yi-Ze, Ai, Chun-Zhi, Zhu, Xin-Xing, Yan, Ya-Wei, Saeed, Yasmeen, Yu, Bin, Huang, Jingying, Gao, Yuxin, Liu, Jiaqi, Jiang, Yi-Zhou, Liu, Min, Chen, Demeng
Publicado 2017

Correction to: CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma

por Chen, Du-Chu, Liang, You-De, Peng, Liang, Wang, Yi-Ze, Ai, Chun-Zhi, Zhu, Xin-Xing, Yan, Ya-Wei, Saeed, Yasmeen, Yu, Bin, Huang, Jingying, Gao, Yuxin, Liu, Jiaqi, Jiang, Yi-Zhou, Liu, Min, Chen, Demeng
Publicado 2018

Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma

por Chen, Demeng, Zhao, Zhiqiang, Huang, Zixin, Chen, Du-Chu, Zhu, Xin-Xing, Wang, Yi-Ze, Yan, Ya-Wei, Tang, Shaojun, Madhavan, Subha, Ni, Weiyi, Huang, Zhan-peng, Li, Wen, Ji, Weidong, Shen, Huangxuan, Lin, Shuibin, Jiang, Yi-Zhou
Publicado 2018